TMOD-42. PROSPECTIVE VALIDATION OF AN EX VIVO 3D ASSAY FOR PREDICTION OF TEMOZOLOMIDE RESPONSE IN GLIOBLASTOMA

Standard treatment for newly diagnosed glioblastoma (GBM) is surgical resection followed by radiation with concurrent temozolomide (TMZ). For those who do not respond there are few clinical options, survival is low, and there no biomarkers to direct the decision of second-line treatment. We have dev...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Smith, Ashley, Holmes, Lillia, Shuford, Stephen, Kanos, Charles, Gardner, Stephen, Hodge, Philip, Lynn, Michael, Edenfield, Jeff, DesRochers, Teresa
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2019
Konular:
Tumor Models
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6845946/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.1141
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller